//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,678.50-119.4
Stock Analysis, IPO, Mutual Funds, Bonds & More

Natco Pharma Ltd.

ET 500

Rank 2019
490
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:59 | 26-02-2020
  • BSE
    16:01 | 26-02-2020
623.50

Today's Change

-11.55 (-1.82%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

74,548

Open

630.00

Prev. Close

635.05

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)2.00
  • EPS-TTM (Rs.)26.80
  • BV/share (₹)191.03
  • 52Wk L/H480.00/ 738.10
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
Natco Pharma Ltd.Record Date 25Th February, 2020| Announcement
Natco Pharma Ltd.Corporate Action-Board approves Dividend| Announcement
Natco Pharma Ltd.Outcome Of Board Meeting| Announcement
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Natco Pharma Ltd.Board to consider FY19 results & Third Interim Dividend on Feb 12, 2020| Announcement
Natco Pharma Ltd.Board Meeting Intimation for Notice Of Board Meeting| Announcement
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS| Announcement
Natco Pharma Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Natco Pharma Ltd.Shareholding for the Period Ended December 31, 2019| Announcement
Natco Pharma Ltd.Statement Of Investor Complaints For The Quarter Ended December 2019| Announcement
Natco Pharma Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
Natco Pharma Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Natco Pharma Ltd.Closure of Trading Window| Announcement
Natco Pharma Ltd.Related Party Transactions For The Half Year Ended September 30,2019| Announcement
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Updates on Acquisition| Announcement
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Natco Pharma Ltd.Fixes Record Date for Second Interim Dividend| Announcement
Natco dares Novartis with new heart drug| News

Natco Pharma Ltd. Share Price Updates

Natco Pharma Ltd. share price down by -1.82% from its previous close of Rs 635.05. Natco Pharma Ltd. stock last traded price is 623.50
Natco Pharma Ltd. Share Price
Value
Today/Current/Last
623.50
Previous Day
635.05
What's your view on Natco Pharma for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Natco Pharma Ltd.

Natco Pharma Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
482.20
-0.72
-13.38
0.00
8154.85
Other Operating Income
0.00
0.00
0.00
0.00
136.45
Operating Profit
128.70
-4.17
-38.24
-27.67
2683.77
Other Income
30.80
-7.23
32.19
-0.05
119.88
EBITDA
159.50
-4.78
-31.16
-27.67
2683.77
Interest
5.30
-14.52
-15.87
-0.10
111.00
Depreciation
25.40
15.98
22.71
0.00
546.99
Tax
24.40
12.44
-46.26
-9.24
767.02
Net Profit
104.50
-12.18
-34.48
-835.00
1019.38
EPS (₹)
5.73
-12.25
-33.60
-94.30
31.95

Natco Pharma Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
623.50
-1.82
-2.02
-5.55
9.03
8.36
-23.05
133.73
295.90
1.30
-5.15
-15.64
-13.34
-49.74
-68.30
-61.58
154.65
-2.95
-5.50
-16.79
-7.15
-9.27
-51.40
-58.24
419.75
-2.55
-2.41
1.87
24.78
25.47
-19.46
0.00
413.35
-2.05
-7.28
-18.88
-2.74
-31.64
0.00
0.00
306.90
-0.62
-0.18
-0.11
-1.41
5.25
19.84
0.00
1414.00
-0.41
8.87
19.81
39.38
41.48
-17.13
28.61
647.55
0.15
0.40
9.78
16.67
21.14
12.12
66.04
1378.70
-3.43
4.81
12.63
23.44
72.26
154.96
106.93
509.25
-1.70
2.80
-18.09
-1.38
-34.27
-28.12
220.28
999.70
-1.99
0.36
17.53
25.25
44.00
159.36
585.99
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Natco Pharma Ltd Risk Return Comparison

with peersNew

Natco Pharma Ltd
Financial Comparison

with peers
Management Efficiency
Natco Pharma Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
18.46
8.93
-99.01
47.57
Return on Assets (%)
15.59
5.57
-27.48
26.25
Return on capital Employed (%)
14.20
5.95
-130.86
23.02
Fixed Assets Turnover (x)
0.59
-1.87
-193.68
2.79
Profitability and Growth
Gross Profit Margin (%)
34.07
-8.25
-980.00
34.42
Operating Profit Margin(%)
37.94
0.75
-896.19
37.94
Net Profit margin (%)
30.76
1.91
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
4.09
1.62
0.08
9.50
Current Ratio (x)
5.33
2.36
0.21
9.50
Cash ratio (x)
0.66
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.00
0.29
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
0.53
3.92
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Natco Pharma Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters86,646,50547.64
ForeignInstitutions39,976,08521.98
GeneralPublic27,788,78415.28
NBanksMutualFunds14,368,0287.90
Others7,494,5554.12
FinancialInstitutions3,174,8531.75
ForeignPromoter2,438,5401.34

MF Ownership Of Natco Pharma Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Franklin India Focused Equity Direct-G
Portfolio as on 31-01-2020
Equity: Multi Cap
2400000
-7.69%
1.7%
152.12
Equity: Large & MidCap
1962297
0.00%
2.47%
124.38
Mirae Asset Emerging Bluechip Direct-G
Portfolio as on 31-01-2020
Equity: Large & MidCap
1789671
-8.96%
1.16%
113.44
Sundaram Mid Cap Direct-G
Portfolio as on 31-01-2020
Equity: Mid Cap
1505613
16.21%
1.54%
95.43
ICICI Pru Multicap Direct-G
Portfolio as on 31-01-2020
Equity: Multi Cap
1008639
15.52%
1.23%
63.93

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Natco Pharma Ltd.

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 11351.03 Crore) operating in Pharmaceuticals sector.

Natco Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1931.70 Crore to Sales Value (97.25 % of Total Sales), Export Incentives which contributed Rs 29.70 Crore to Sales Value (1.49 % of Total Sales), Job Work which contributed Rs 15.00 Crore to Sales Value (0.75 % of Total Sales), Sale of services which contributed Rs 6.80 Crore to Sales Value (0.34 % of Total Sales) and Scrap which contributed Rs 3.10 Crore to Sales Value (0.15 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 482.20 Crore, down -.72 % from last quarter Sales of Rs 485.70 Crore and down -13.38 % from last year same quarter Sales of Rs 556.70 Crore Company has reported net profit after tax of Rs 104.40 Crore in latest quarter.

The company’s top management includes Dr.D Linga Rao, Mr.V C Nannapaneni, Mr.T V Rao, Mr.Rajeev Nannapaneni, Mr.P S R K Prasad, Mr.G S Murthy, Mr.D G Prasad, Dr.(Mrs.)Leela Digumarti, Dr.M U R Naidu, Mr.Vivek Chhachhi. Company has Walker, Chandiok & Co.LLP as its auditors As on 31-12-2019, the company has a total of 181,887,350 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors